Postgraduate Courses

14-1-2025 Interesting cases[P.V. Voulgari]]

21-1-2025 Interesting cases[A.A. Drosos]]

28-1-2025 What rheumatologists need to know about mRNA vaccines: rheumatic diseases[N. Gerolymatou]]

4-2-2025 Cryoglobulinemia[T-E. Memi]]

11-2-2025 EULAR recommendations for the treatment of systemic sclerosis: 2023 update[M. karakosta]]

18-2-2025 Pathological autoantibody internalisation in myositis[N. Koletsos-Soultis]]

25-2-2025 Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations[T.E. Markatseli]]

4-3-2025 Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease Olokizumab plus methotrexate: safety and efficacy over 106
weeks of treatment[L. Magkou]]

11-3-2025 Where are we now in biologic drugs for myositis?[M. Koletsi]]

18-3-2025 Inclusion body myositis and immunosenescence: current evidence and future perspectives[K. Pelekoudas]]

1-4-2025 Recent advances in the diagnosis and management of neuropsychiatric lupus[M. karakosta]]

8-4-2025 Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy[N. Koletsos-Soultis]]

15-4-2024 Holiday Easter

22-4-2024 Holiday Easter

29-4-2025 Extraarticular manifestations of sarcoidosis[E. Kaltsonoudis]]   

6-5-2025 Pulmonary artery involvement due to Behçet's syndrome and Hughes Stovin syndrome: a comparative study[A. N. Georgiadis]]   

13-5-2025 Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome[L. Magkou]] 

20-5-2025 IgA vasculitis with nephritis: an overview of the pathogenesis and clinical characteristic[K. Pelekoudas]] 

27-5-2025 The association between rheumatoid arthritis and left ventricular diastolic dysfunction: pathogenesis, predictors and managements[M. Koletsi]]

3-6-2025 Test